HomeTYP • ASX
add
Tryptamine Therapeutics Ltd
Previous close
$0.032
Day range
$0.031 - $0.032
Year range
$0.017 - $0.057
Market cap
47.45M AUD
Avg Volume
1.75M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 790.84K | — |
Operating expense | 1.07M | — |
Net income | -653.06K | — |
Net profit margin | -82.58 | — |
Earnings per share | — | — |
EBITDA | -572.94K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.03M | — |
Total assets | 6.66M | — |
Total liabilities | 699.17K | — |
Total equity | 5.96M | — |
Shares outstanding | 1.39B | — |
Price to book | ∞ | — |
Return on assets | -22.14% | — |
Return on capital | -24.73% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -653.06K | — |
Cash from operations | -1.37M | — |
Cash from investing | -6.34K | — |
Cash from financing | 1.52M | — |
Net change in cash | 99.41K | — |
Free cash flow | -367.55K | — |
About
Founded
2019
Website
